Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Braess

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Haematologica|July 15, 2021
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Hatice G Ozer, Deedra Nicolet, et al.
Haematologica|June 16, 2022
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Communications Medicine|May 17, 2023
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profilesJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Cancers|September 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity TherapyKatja Krüger, Razif Gabdoulline, Martin Wichmann, et al.
Nature Communications|June 3, 2016
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocationLuise Hartmann, Sayantanee Dutta, Sabrina Opatz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020
Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of ImmunotherapyAnna Kron, Matthias Scheffler, Carina Heydt, et al.
Leukemia|January 16, 2024
Prognostic impact of CEBPA mutational subgroups in adult AMLJulia-Annabell Georgi, Sebastian Stasik, Michael Kramer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Uta M Demel, Anne-Katrin Fietz, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Journal of Hematology & Oncology|September 5, 2022
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantationDesiree Kunadt, Sebastian Stasik, Klaus H Metzeler, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Haematologica|July 15, 2021
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Hatice G Ozer, Deedra Nicolet, et al.
Haematologica|June 16, 2022
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Communications Medicine|May 17, 2023
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profilesJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Cancers|September 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity TherapyKatja Krüger, Razif Gabdoulline, Martin Wichmann, et al.
Nature Communications|June 3, 2016
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocationLuise Hartmann, Sayantanee Dutta, Sabrina Opatz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020
Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of ImmunotherapyAnna Kron, Matthias Scheffler, Carina Heydt, et al.
Leukemia|January 16, 2024
Prognostic impact of CEBPA mutational subgroups in adult AMLJulia-Annabell Georgi, Sebastian Stasik, Michael Kramer, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Uta M Demel, Anne-Katrin Fietz, et al.
Leukemia|September 19, 2025
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)Monica Cusan, Karilyn Larkin, Deedra Nicolet, et al.
Journal of Hematology & Oncology|September 5, 2022
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantationDesiree Kunadt, Sebastian Stasik, Klaus H Metzeler, et al.
Pageof 9